Counselors in Fairhaven, MA Accepting Medicare

10 Counselors found. Showing 1 - 10

Mr. Mathew Barbosa, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 16 Sconticut Neck Rd # 237, Fairhaven, MA 02719 Phone: 774-377-5171

Timothy Hernandez, LADC I Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 295 Sconticut Neck Rd, Fairhaven, MA 02719 Phone: 508-863-6733

Amy Dubreuil Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 134 Bridge St, Fairhaven, MA 02719 Phone: 508-415-2756

Patrice Nogueira Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 2 New Boston Rd, Fairhaven, MA 02719 Phone: 508-979-4058

Ms. Fay R Bartling I, RN, LMHC, LADAC1 Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 12 Middle St, Fairhaven, MA 02719 Phone: 508-292-9055

Danielle Fournier Counselor Medicare: Not Enrolled in Medicare Practice Location: 105 Center St, Fairhaven, MA 02719 Phone: 508-509-5084

Dr. Theresa Jean Soucie, D.C. Counselor - Mental Health Medicare: Accepting Medicare Assignments Practice Location: 270 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-997-9100    Fax: 508-993-5854

Myles Kennedy, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 258 Adams St, Fairhaven, MA 02719 Phone: 508-742-5508

Michael Pacheco Jr., MED, LMHC Counselor Medicare: Medicare Enrolled Practice Location: 3 Academy Ave, Fairhaven, MA 02719 Phone: 508-315-7261

Rebecca J Carney, LMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 200 Mill Rd Ste 180, Fairhaven, MA 02719 Phone: 508-973-2000    Fax: 508-973-2001

News Archive

A counter to claims that extending Medicaid drug rebates would help reduce deficit

Rep. Henry Waxman and Sen. Jay Rockefeller have introduced legislation that would extend Medicaid rebates to "dual eligibles" and those who qualify for the low-income subsidy program — a plan they say could reduce the deficit by $112 billion over the next ten years.

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.

Antibody-based eye drop treatment reduces signs and symptoms of dry eye disease

Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid.

Paragonix Technologies files FDA Pre-Marketing Notification Application for Sherpa Pak Transporter

Paragonix Technologies, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration for its Sherpa Pak Transporter. The Sherpa Pak Transporter is indicated for the static hypothermic preservation of kidneys during transportation and eventual transplantation into a recipient, using cold storage solutions indicated for use with the kidney.

Alcohol Consumption Decreases Risk of Heart Disease in Men

Cardiovascular disease, including heart disease and stroke, is the leading cause of death in the United States. To help combat this epidemic, studies throughout the United States pinpoint dietary guidelines to reduce risk including a recent release from the American Heart Association which stated that hypertensive patients should avoid alcoholic beverages.

Read more Medical News

› Verified 3 days ago